Publication	Data		Fish	Anatomy
Parial et al., 2021	Fig. 1		mettl3hzu103/+; y1Tg ,   mettl3hzu103/+; la116Tg	intersegmental vessel decreased length, abnormal intersegmental vessel morphology, abnormal whole organism lacks parts or has fewer parts of type intersegmental vessel, abnormal
	Fig. 2		mettl3hzu103/+ ,   mettl3hzu103/+; la116Tg	dorsal longitudinal anastomotic vessel decreased branchiness, abnormal dorsal longitudinal anastomotic vessel morphology, abnormal interconnecting vessels decreased branchiness, abnormal subintestinal vein decreased branchiness, abnormal subintestinal vein morphology, abnormal
	Fig. 3		mettl3hzu103/+ ,   mettl3hzu103/hzu103	intersegmental vein morphology, abnormal vasculature development process quality, abnormal whole organism lacks parts or has fewer parts of type intersegmental vessel, abnormal
	Fig. 4		y1Tg + MO2-mettl3 ,   la116Tg + MO2-mettl3	vasculature development process quality, abnormal whole organism lacks parts or has fewer parts of type intersegmental vessel, abnormal
	Fig. 6		WT + MO2-mettl3 ,   mettl3hzu103/hzu103	whole organism Ab1-phlpp2 labeling increased amount, abnormal whole organism Ab17-akt labeling decreased amount, abnormal whole organism Ab18-akt labeling increased amount, abnormal whole organism Ab2-mettl3 labeling decreased amount, abnormal
	Fig. S1		mettl3hzu103/+ ,   mettl3hzu103/hzu103	mRNA m(6)A methyltransferase activity decreased occurrence, abnormal whole organism Ab2-mettl3 labeling decreased amount, abnormal
Xia et al., 2017	Fig. 10		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	blood 11-oxotestosterone decreased amount, abnormal blood estradiol decreased amount, abnormal
	Fig. 3		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	brain mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity decreased occurrence, abnormal liver mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity decreased occurrence, abnormal muscle mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity decreased occurrence, abnormal ovary mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity decreased occurrence, abnormal testis mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity decreased occurrence, abnormal
	Fig. 4		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	ovary decreased size, abnormal ovary has fewer parts of type ovarian follicle stage IV, abnormal
	Fig. 5		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	oocyte stage IV meiosis II nuclear membrane disassembly disrupted, abnormal oocyte stage IV oocyte maturation disrupted, abnormal
	Fig. 6		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	testis decreased size, abnormal testis has extra parts of type spermatocyte, abnormal testis has extra parts of type spermatogonium, abnormal testis lacks parts or has fewer parts of type sperm, abnormal
	Fig. 8		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	female organism decreased female fertility, abnormal female organism has fewer parts of type oocyte stage V, abnormal female organism ovulation decreased rate, abnormal female organism ratio male organism, abnormal sex determination process quality, abnormal
	Fig. 9		mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB)	female organism hypophysis lhb expression decreased amount, abnormal male organism hypophysis fshb expression decreased amount, abnormal ovarian follicle stage IV cyp19a1a expression decreased amount, abnormal ovarian follicle stage IV fsta expression increased amount, abnormal ovarian follicle stage IV hsd3b2 expression decreased amount, abnormal ovarian follicle stage IV igf3 expression decreased amount, abnormal ovarian follicle stage IV pgr expression decreased amount, abnormal ovarian follicle stage IV star expression decreased amount, abnormal testis cyp11a1.1 expression decreased amount, abnormal testis cyp17a1 expression decreased amount, abnormal testis cyp17a2 expression decreased amount, abnormal testis fshr expression decreased amount, abnormal testis hsd17b3 expression decreased amount, abnormal testis hsd3b2 expression decreased amount, abnormal testis star expression decreased amount, abnormal
	text only		mettl3ihb306/ihb306 (AB) ,   mettl3ihb306/ihb306 (AB) ,   mettl3ihb307/ihb307 (AB) ,   mettl3ihb307/ihb307 (AB)	flagellated sperm motility decreased process quality, abnormal whole organism brood viability, abnormal whole organism dead, abnormal whole organism viability, abnormal
Zhang et al., 2017	Fig. 2		ioz1Tg; s896Tg + MO1-mettl3 ,   TU + MO1-mettl3	thymus has fewer parts of type T cell, abnormal thymus lymphocyte EGFP expression decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell gata1a expression decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell rag1 expression decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell spi1b expression decreased amount, abnormal ventral wall of dorsal aorta hematopoietic multipotent progenitor cell EGFP expression decreased amount, abnormal ventral wall of dorsal aorta lacks parts or has fewer parts of type hematopoietic multipotent progenitor cell, abnormal
	Fig. 3		jh11Tg; y1Tg + MO1-mettl3 ,   TU + MO1-mettl3	endothelial cell notch1a expression increased amount, abnormal endothelial cell EGFP expression increased amount, abnormal whole organism runx1 expression decreased amount, abnormal whole organism Ab3-notch1 labeling increased amount, abnormal
	text only		mettl3ioz12/ioz12	whole organism dead, abnormal
Ping et al., 2014	Fig. 2		WT + MO1-mettl3	apoptotic process increased process quality, abnormal eye decreased size, abnormal head decreased size, abnormal notochord curved ventral, abnormal ventricular system decreased size, abnormal
	Fig. 4		WT + MO1-mettl3	somite myod1 expression increased amount, abnormal